Global Flu (Influenza) Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
LPI (LP Information)' newest research report, the “Flu (Influenza) Vaccine Industry Forecast” looks at past sales and reviews total world Flu (Influenza) Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Flu (Influenza) Vaccine sales for 2023 through 2029. With Flu (Influenza) Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu (Influenza) Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Flu (Influenza) Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu (Influenza) Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Flu (Influenza) Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu (Influenza) Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu (Influenza) Vaccine.
The global Flu (Influenza) Vaccine market size is projected to grow from US$ 5385.3 million in 2022 to US$ 6961 million in 2029; it is expected to grow at a CAGR of 6961 from 2023 to 2029.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents a comprehensive overview, market shares, and growth opportunities of Flu (Influenza) Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Flu (Influenza) Vaccine market?
What factors are driving Flu (Influenza) Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flu (Influenza) Vaccine market opportunities vary by end market size?
How does Flu (Influenza) Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
LPI (LP Information)' newest research report, the “Flu (Influenza) Vaccine Industry Forecast” looks at past sales and reviews total world Flu (Influenza) Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Flu (Influenza) Vaccine sales for 2023 through 2029. With Flu (Influenza) Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu (Influenza) Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Flu (Influenza) Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu (Influenza) Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Flu (Influenza) Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu (Influenza) Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu (Influenza) Vaccine.
The global Flu (Influenza) Vaccine market size is projected to grow from US$ 5385.3 million in 2022 to US$ 6961 million in 2029; it is expected to grow at a CAGR of 6961 from 2023 to 2029.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents a comprehensive overview, market shares, and growth opportunities of Flu (Influenza) Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Split Influenza Vaccine
- Pandemic Influenza Vaccine
- Subunit Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hualan Bio
- CCBIO
- Aleph Biomedical
- SANOFI
- Adimmune
- ZYAK
- SINOVAC
- Changsheng Biological
- SIOBP
- GSK
- Aimei Hissen
- Tianyuan Bio-pharma(Novartis)
- Simcere Vaxtec
What is the 10-year outlook for the global Flu (Influenza) Vaccine market?
What factors are driving Flu (Influenza) Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flu (Influenza) Vaccine market opportunities vary by end market size?
How does Flu (Influenza) Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flu (Influenza) Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Flu (Influenza) Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Flu (Influenza) Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Flu (Influenza) Vaccine Segment by Type
2.2.1 Split Influenza Vaccine
2.2.2 Pandemic Influenza Vaccine
2.2.3 Subunit Influenza Vaccine
2.2.4 Quadrivalent Influenza Vaccine
2.3 Flu (Influenza) Vaccine Sales by Type
2.3.1 Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Flu (Influenza) Vaccine Sale Price by Type (2018-2023)
2.4 Flu (Influenza) Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu (Influenza) Vaccine Sales by Application
2.5.1 Global Flu (Influenza) Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Flu (Influenza) Vaccine Sale Price by Application (2018-2023)
3 GLOBAL FLU (INFLUENZA) VACCINE BY COMPANY
3.1 Global Flu (Influenza) Vaccine Breakdown Data by Company
3.1.1 Global Flu (Influenza) Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Flu (Influenza) Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Flu (Influenza) Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Flu (Influenza) Vaccine Revenue by Company (2018-2023)
3.2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Flu (Influenza) Vaccine Sale Price by Company
3.4 Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flu (Influenza) Vaccine Product Location Distribution
3.4.2 Players Flu (Influenza) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FLU (INFLUENZA) VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Flu (Influenza) Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Flu (Influenza) Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Flu (Influenza) Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Flu (Influenza) Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Flu (Influenza) Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Flu (Influenza) Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Flu (Influenza) Vaccine Sales Growth
4.4 APAC Flu (Influenza) Vaccine Sales Growth
4.5 Europe Flu (Influenza) Vaccine Sales Growth
4.6 Middle East & Africa Flu (Influenza) Vaccine Sales Growth
5 AMERICAS
5.1 Americas Flu (Influenza) Vaccine Sales by Country
5.1.1 Americas Flu (Influenza) Vaccine Sales by Country (2018-2023)
5.1.2 Americas Flu (Influenza) Vaccine Revenue by Country (2018-2023)
5.2 Americas Flu (Influenza) Vaccine Sales by Type
5.3 Americas Flu (Influenza) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flu (Influenza) Vaccine Sales by Region
6.1.1 APAC Flu (Influenza) Vaccine Sales by Region (2018-2023)
6.1.2 APAC Flu (Influenza) Vaccine Revenue by Region (2018-2023)
6.2 APAC Flu (Influenza) Vaccine Sales by Type
6.3 APAC Flu (Influenza) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flu (Influenza) Vaccine by Country
7.1.1 Europe Flu (Influenza) Vaccine Sales by Country (2018-2023)
7.1.2 Europe Flu (Influenza) Vaccine Revenue by Country (2018-2023)
7.2 Europe Flu (Influenza) Vaccine Sales by Type
7.3 Europe Flu (Influenza) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flu (Influenza) Vaccine by Country
8.1.1 Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Flu (Influenza) Vaccine Sales by Type
8.3 Middle East & Africa Flu (Influenza) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine
10.3 Manufacturing Process Analysis of Flu (Influenza) Vaccine
10.4 Industry Chain Structure of Flu (Influenza) Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flu (Influenza) Vaccine Distributors
11.3 Flu (Influenza) Vaccine Customer
12 WORLD FORECAST REVIEW FOR FLU (INFLUENZA) VACCINE BY GEOGRAPHIC REGION
12.1 Global Flu (Influenza) Vaccine Market Size Forecast by Region
12.1.1 Global Flu (Influenza) Vaccine Forecast by Region (2024-2029)
12.1.2 Global Flu (Influenza) Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flu (Influenza) Vaccine Forecast by Type
12.7 Global Flu (Influenza) Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hualan Bio
13.1.1 Hualan Bio Company Information
13.1.2 Hualan Bio Flu (Influenza) Vaccine Product Portfolios and Specifications
13.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hualan Bio Main Business Overview
13.1.5 Hualan Bio Latest Developments
13.2 CCBIO
13.2.1 CCBIO Company Information
13.2.2 CCBIO Flu (Influenza) Vaccine Product Portfolios and Specifications
13.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CCBIO Main Business Overview
13.2.5 CCBIO Latest Developments
13.3 Aleph Biomedical
13.3.1 Aleph Biomedical Company Information
13.3.2 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolios and Specifications
13.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aleph Biomedical Main Business Overview
13.3.5 Aleph Biomedical Latest Developments
13.4 SANOFI
13.4.1 SANOFI Company Information
13.4.2 SANOFI Flu (Influenza) Vaccine Product Portfolios and Specifications
13.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 SANOFI Main Business Overview
13.4.5 SANOFI Latest Developments
13.5 Adimmune
13.5.1 Adimmune Company Information
13.5.2 Adimmune Flu (Influenza) Vaccine Product Portfolios and Specifications
13.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Adimmune Main Business Overview
13.5.5 Adimmune Latest Developments
13.6 ZYAK
13.6.1 ZYAK Company Information
13.6.2 ZYAK Flu (Influenza) Vaccine Product Portfolios and Specifications
13.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ZYAK Main Business Overview
13.6.5 ZYAK Latest Developments
13.7 SINOVAC
13.7.1 SINOVAC Company Information
13.7.2 SINOVAC Flu (Influenza) Vaccine Product Portfolios and Specifications
13.7.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 SINOVAC Main Business Overview
13.7.5 SINOVAC Latest Developments
13.8 Changsheng Biological
13.8.1 Changsheng Biological Company Information
13.8.2 Changsheng Biological Flu (Influenza) Vaccine Product Portfolios and Specifications
13.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Changsheng Biological Main Business Overview
13.8.5 Changsheng Biological Latest Developments
13.9 SIOBP
13.9.1 SIOBP Company Information
13.9.2 SIOBP Flu (Influenza) Vaccine Product Portfolios and Specifications
13.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SIOBP Main Business Overview
13.9.5 SIOBP Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Flu (Influenza) Vaccine Product Portfolios and Specifications
13.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Aimei Hissen
13.11.1 Aimei Hissen Company Information
13.11.2 Aimei Hissen Flu (Influenza) Vaccine Product Portfolios and Specifications
13.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aimei Hissen Main Business Overview
13.11.5 Aimei Hissen Latest Developments
13.12 Tianyuan Bio-pharma(Novartis)
13.12.1 Tianyuan Bio-pharma(Novartis) Company Information
13.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolios and Specifications
13.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Tianyuan Bio-pharma(Novartis) Main Business Overview
13.12.5 Tianyuan Bio-pharma(Novartis) Latest Developments
13.13 Simcere Vaxtec
13.13.1 Simcere Vaxtec Company Information
13.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolios and Specifications
13.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Simcere Vaxtec Main Business Overview
13.13.5 Simcere Vaxtec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flu (Influenza) Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Flu (Influenza) Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Flu (Influenza) Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Flu (Influenza) Vaccine Segment by Type
2.2.1 Split Influenza Vaccine
2.2.2 Pandemic Influenza Vaccine
2.2.3 Subunit Influenza Vaccine
2.2.4 Quadrivalent Influenza Vaccine
2.3 Flu (Influenza) Vaccine Sales by Type
2.3.1 Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Flu (Influenza) Vaccine Sale Price by Type (2018-2023)
2.4 Flu (Influenza) Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu (Influenza) Vaccine Sales by Application
2.5.1 Global Flu (Influenza) Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Flu (Influenza) Vaccine Sale Price by Application (2018-2023)
3 GLOBAL FLU (INFLUENZA) VACCINE BY COMPANY
3.1 Global Flu (Influenza) Vaccine Breakdown Data by Company
3.1.1 Global Flu (Influenza) Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Flu (Influenza) Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Flu (Influenza) Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Flu (Influenza) Vaccine Revenue by Company (2018-2023)
3.2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Flu (Influenza) Vaccine Sale Price by Company
3.4 Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flu (Influenza) Vaccine Product Location Distribution
3.4.2 Players Flu (Influenza) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FLU (INFLUENZA) VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Flu (Influenza) Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Flu (Influenza) Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Flu (Influenza) Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Flu (Influenza) Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Flu (Influenza) Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Flu (Influenza) Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Flu (Influenza) Vaccine Sales Growth
4.4 APAC Flu (Influenza) Vaccine Sales Growth
4.5 Europe Flu (Influenza) Vaccine Sales Growth
4.6 Middle East & Africa Flu (Influenza) Vaccine Sales Growth
5 AMERICAS
5.1 Americas Flu (Influenza) Vaccine Sales by Country
5.1.1 Americas Flu (Influenza) Vaccine Sales by Country (2018-2023)
5.1.2 Americas Flu (Influenza) Vaccine Revenue by Country (2018-2023)
5.2 Americas Flu (Influenza) Vaccine Sales by Type
5.3 Americas Flu (Influenza) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flu (Influenza) Vaccine Sales by Region
6.1.1 APAC Flu (Influenza) Vaccine Sales by Region (2018-2023)
6.1.2 APAC Flu (Influenza) Vaccine Revenue by Region (2018-2023)
6.2 APAC Flu (Influenza) Vaccine Sales by Type
6.3 APAC Flu (Influenza) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flu (Influenza) Vaccine by Country
7.1.1 Europe Flu (Influenza) Vaccine Sales by Country (2018-2023)
7.1.2 Europe Flu (Influenza) Vaccine Revenue by Country (2018-2023)
7.2 Europe Flu (Influenza) Vaccine Sales by Type
7.3 Europe Flu (Influenza) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flu (Influenza) Vaccine by Country
8.1.1 Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Flu (Influenza) Vaccine Sales by Type
8.3 Middle East & Africa Flu (Influenza) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine
10.3 Manufacturing Process Analysis of Flu (Influenza) Vaccine
10.4 Industry Chain Structure of Flu (Influenza) Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flu (Influenza) Vaccine Distributors
11.3 Flu (Influenza) Vaccine Customer
12 WORLD FORECAST REVIEW FOR FLU (INFLUENZA) VACCINE BY GEOGRAPHIC REGION
12.1 Global Flu (Influenza) Vaccine Market Size Forecast by Region
12.1.1 Global Flu (Influenza) Vaccine Forecast by Region (2024-2029)
12.1.2 Global Flu (Influenza) Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flu (Influenza) Vaccine Forecast by Type
12.7 Global Flu (Influenza) Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hualan Bio
13.1.1 Hualan Bio Company Information
13.1.2 Hualan Bio Flu (Influenza) Vaccine Product Portfolios and Specifications
13.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hualan Bio Main Business Overview
13.1.5 Hualan Bio Latest Developments
13.2 CCBIO
13.2.1 CCBIO Company Information
13.2.2 CCBIO Flu (Influenza) Vaccine Product Portfolios and Specifications
13.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CCBIO Main Business Overview
13.2.5 CCBIO Latest Developments
13.3 Aleph Biomedical
13.3.1 Aleph Biomedical Company Information
13.3.2 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolios and Specifications
13.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aleph Biomedical Main Business Overview
13.3.5 Aleph Biomedical Latest Developments
13.4 SANOFI
13.4.1 SANOFI Company Information
13.4.2 SANOFI Flu (Influenza) Vaccine Product Portfolios and Specifications
13.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 SANOFI Main Business Overview
13.4.5 SANOFI Latest Developments
13.5 Adimmune
13.5.1 Adimmune Company Information
13.5.2 Adimmune Flu (Influenza) Vaccine Product Portfolios and Specifications
13.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Adimmune Main Business Overview
13.5.5 Adimmune Latest Developments
13.6 ZYAK
13.6.1 ZYAK Company Information
13.6.2 ZYAK Flu (Influenza) Vaccine Product Portfolios and Specifications
13.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ZYAK Main Business Overview
13.6.5 ZYAK Latest Developments
13.7 SINOVAC
13.7.1 SINOVAC Company Information
13.7.2 SINOVAC Flu (Influenza) Vaccine Product Portfolios and Specifications
13.7.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 SINOVAC Main Business Overview
13.7.5 SINOVAC Latest Developments
13.8 Changsheng Biological
13.8.1 Changsheng Biological Company Information
13.8.2 Changsheng Biological Flu (Influenza) Vaccine Product Portfolios and Specifications
13.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Changsheng Biological Main Business Overview
13.8.5 Changsheng Biological Latest Developments
13.9 SIOBP
13.9.1 SIOBP Company Information
13.9.2 SIOBP Flu (Influenza) Vaccine Product Portfolios and Specifications
13.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SIOBP Main Business Overview
13.9.5 SIOBP Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Flu (Influenza) Vaccine Product Portfolios and Specifications
13.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Aimei Hissen
13.11.1 Aimei Hissen Company Information
13.11.2 Aimei Hissen Flu (Influenza) Vaccine Product Portfolios and Specifications
13.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aimei Hissen Main Business Overview
13.11.5 Aimei Hissen Latest Developments
13.12 Tianyuan Bio-pharma(Novartis)
13.12.1 Tianyuan Bio-pharma(Novartis) Company Information
13.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolios and Specifications
13.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Tianyuan Bio-pharma(Novartis) Main Business Overview
13.12.5 Tianyuan Bio-pharma(Novartis) Latest Developments
13.13 Simcere Vaxtec
13.13.1 Simcere Vaxtec Company Information
13.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolios and Specifications
13.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Simcere Vaxtec Main Business Overview
13.13.5 Simcere Vaxtec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Flu (Influenza) Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Flu (Influenza) Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Split Influenza Vaccine
Table 4. Major Players of Pandemic Influenza Vaccine
Table 5. Major Players of Subunit Influenza Vaccine
Table 6. Major Players of Quadrivalent Influenza Vaccine
Table 7. Global Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 8. Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Flu (Influenza) Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Flu (Influenza) Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 13. Global Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Flu (Influenza) Vaccine Revenue by Application (2018-2023)
Table 15. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Flu (Influenza) Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Flu (Influenza) Vaccine Sales by Company (2018-2023) & (K Units)
Table 18. Global Flu (Influenza) Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Flu (Influenza) Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Flu (Influenza) Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Flu (Influenza) Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution and Sales Area
Table 23. Players Flu (Influenza) Vaccine Products Offered
Table 24. Flu (Influenza) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Flu (Influenza) Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Flu (Influenza) Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Flu (Influenza) Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Flu (Influenza) Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Flu (Influenza) Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Flu (Influenza) Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Flu (Influenza) Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 36. Americas Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 40. Americas Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 41. APAC Flu (Influenza) Vaccine Sales by Region (2018-2023) & (K Units)
Table 42. APAC Flu (Influenza) Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Flu (Influenza) Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Flu (Influenza) Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 46. APAC Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 47. Europe Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 48. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 52. Europe Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Flu (Influenza) Vaccine
Table 60. Key Market Challenges & Risks of Flu (Influenza) Vaccine
Table 61. Key Industry Trends of Flu (Influenza) Vaccine
Table 62. Flu (Influenza) Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Flu (Influenza) Vaccine Distributors List
Table 65. Flu (Influenza) Vaccine Customer List
Table 66. Global Flu (Influenza) Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Flu (Influenza) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Flu (Influenza) Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Flu (Influenza) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Flu (Influenza) Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Flu (Influenza) Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Flu (Influenza) Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Flu (Influenza) Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Hualan Bio Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Hualan Bio Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 82. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Hualan Bio Main Business
Table 84. Hualan Bio Latest Developments
Table 85. CCBIO Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. CCBIO Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 87. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. CCBIO Main Business
Table 89. CCBIO Latest Developments
Table 90. Aleph Biomedical Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Aleph Biomedical Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 92. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Aleph Biomedical Main Business
Table 94. Aleph Biomedical Latest Developments
Table 95. SANOFI Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. SANOFI Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 97. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. SANOFI Main Business
Table 99. SANOFI Latest Developments
Table 100. Adimmune Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Adimmune Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 102. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Adimmune Main Business
Table 104. Adimmune Latest Developments
Table 105. ZYAK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. ZYAK Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 107. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ZYAK Main Business
Table 109. ZYAK Latest Developments
Table 110. SINOVAC Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. SINOVAC Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 112. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. SINOVAC Main Business
Table 114. SINOVAC Latest Developments
Table 115. Changsheng Biological Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Changsheng Biological Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 117. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Changsheng Biological Main Business
Table 119. Changsheng Biological Latest Developments
Table 120. SIOBP Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. SIOBP Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 122. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. SIOBP Main Business
Table 124. SIOBP Latest Developments
Table 125. GSK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. GSK Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 127. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. GSK Main Business
Table 129. GSK Latest Developments
Table 130. Aimei Hissen Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Aimei Hissen Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 132. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Aimei Hissen Main Business
Table 134. Aimei Hissen Latest Developments
Table 135. Tianyuan Bio-pharma(Novartis) Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 137. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Tianyuan Bio-pharma(Novartis) Main Business
Table 139. Tianyuan Bio-pharma(Novartis) Latest Developments
Table 140. Simcere Vaxtec Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 142. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Simcere Vaxtec Main Business
Table 144. Simcere Vaxtec Latest Developments
Table 1. Flu (Influenza) Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Flu (Influenza) Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Split Influenza Vaccine
Table 4. Major Players of Pandemic Influenza Vaccine
Table 5. Major Players of Subunit Influenza Vaccine
Table 6. Major Players of Quadrivalent Influenza Vaccine
Table 7. Global Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 8. Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Flu (Influenza) Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Flu (Influenza) Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 13. Global Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Flu (Influenza) Vaccine Revenue by Application (2018-2023)
Table 15. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Flu (Influenza) Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Flu (Influenza) Vaccine Sales by Company (2018-2023) & (K Units)
Table 18. Global Flu (Influenza) Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Flu (Influenza) Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Flu (Influenza) Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Flu (Influenza) Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution and Sales Area
Table 23. Players Flu (Influenza) Vaccine Products Offered
Table 24. Flu (Influenza) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Flu (Influenza) Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Flu (Influenza) Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Flu (Influenza) Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Flu (Influenza) Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Flu (Influenza) Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Flu (Influenza) Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Flu (Influenza) Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 36. Americas Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 40. Americas Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 41. APAC Flu (Influenza) Vaccine Sales by Region (2018-2023) & (K Units)
Table 42. APAC Flu (Influenza) Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Flu (Influenza) Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Flu (Influenza) Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 46. APAC Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 47. Europe Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 48. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 52. Europe Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Flu (Influenza) Vaccine Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Flu (Influenza) Vaccine Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Flu (Influenza) Vaccine
Table 60. Key Market Challenges & Risks of Flu (Influenza) Vaccine
Table 61. Key Industry Trends of Flu (Influenza) Vaccine
Table 62. Flu (Influenza) Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Flu (Influenza) Vaccine Distributors List
Table 65. Flu (Influenza) Vaccine Customer List
Table 66. Global Flu (Influenza) Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Flu (Influenza) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Flu (Influenza) Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Flu (Influenza) Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Flu (Influenza) Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Flu (Influenza) Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Flu (Influenza) Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Flu (Influenza) Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Flu (Influenza) Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Flu (Influenza) Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Hualan Bio Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Hualan Bio Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 82. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Hualan Bio Main Business
Table 84. Hualan Bio Latest Developments
Table 85. CCBIO Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. CCBIO Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 87. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. CCBIO Main Business
Table 89. CCBIO Latest Developments
Table 90. Aleph Biomedical Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Aleph Biomedical Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 92. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Aleph Biomedical Main Business
Table 94. Aleph Biomedical Latest Developments
Table 95. SANOFI Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. SANOFI Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 97. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. SANOFI Main Business
Table 99. SANOFI Latest Developments
Table 100. Adimmune Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Adimmune Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 102. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Adimmune Main Business
Table 104. Adimmune Latest Developments
Table 105. ZYAK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. ZYAK Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 107. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ZYAK Main Business
Table 109. ZYAK Latest Developments
Table 110. SINOVAC Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. SINOVAC Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 112. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. SINOVAC Main Business
Table 114. SINOVAC Latest Developments
Table 115. Changsheng Biological Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Changsheng Biological Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 117. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Changsheng Biological Main Business
Table 119. Changsheng Biological Latest Developments
Table 120. SIOBP Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. SIOBP Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 122. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. SIOBP Main Business
Table 124. SIOBP Latest Developments
Table 125. GSK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. GSK Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 127. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. GSK Main Business
Table 129. GSK Latest Developments
Table 130. Aimei Hissen Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Aimei Hissen Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 132. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Aimei Hissen Main Business
Table 134. Aimei Hissen Latest Developments
Table 135. Tianyuan Bio-pharma(Novartis) Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 137. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Tianyuan Bio-pharma(Novartis) Main Business
Table 139. Tianyuan Bio-pharma(Novartis) Latest Developments
Table 140. Simcere Vaxtec Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolios and Specifications
Table 142. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Simcere Vaxtec Main Business
Table 144. Simcere Vaxtec Latest Developments
LIST OF FIGURES
Figure 1. Picture of Flu (Influenza) Vaccine
Figure 2. Flu (Influenza) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu (Influenza) Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Flu (Influenza) Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Flu (Influenza) Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Split Influenza Vaccine
Figure 10. Product Picture of Pandemic Influenza Vaccine
Figure 11. Product Picture of Subunit Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Flu (Influenza) Vaccine Sales Market Share by Type in 2022
Figure 14. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Flu (Influenza) Vaccine Consumed in For Children (6 months to 3 years)
Figure 16. Global Flu (Influenza) Vaccine Market: For Children (6 months to 3 years) (2018-2023) & (K Units)
Figure 17. Flu (Influenza) Vaccine Consumed in For Adults and Children over 3 years
Figure 18. Global Flu (Influenza) Vaccine Market: For Adults and Children over 3 years (2018-2023) & (K Units)
Figure 19. Global Flu (Influenza) Vaccine Sales Market Share by Application (2022)
Figure 20. Global Flu (Influenza) Vaccine Revenue Market Share by Application in 2022
Figure 21. Flu (Influenza) Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Flu (Influenza) Vaccine Sales Market Share by Company in 2022
Figure 23. Flu (Influenza) Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Flu (Influenza) Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Flu (Influenza) Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Flu (Influenza) Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Flu (Influenza) Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Flu (Influenza) Vaccine
Figure 74. Industry Chain Structure of Flu (Influenza) Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Flu (Influenza) Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Flu (Influenza) Vaccine
Figure 2. Flu (Influenza) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu (Influenza) Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Flu (Influenza) Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Flu (Influenza) Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Split Influenza Vaccine
Figure 10. Product Picture of Pandemic Influenza Vaccine
Figure 11. Product Picture of Subunit Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Flu (Influenza) Vaccine Sales Market Share by Type in 2022
Figure 14. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Flu (Influenza) Vaccine Consumed in For Children (6 months to 3 years)
Figure 16. Global Flu (Influenza) Vaccine Market: For Children (6 months to 3 years) (2018-2023) & (K Units)
Figure 17. Flu (Influenza) Vaccine Consumed in For Adults and Children over 3 years
Figure 18. Global Flu (Influenza) Vaccine Market: For Adults and Children over 3 years (2018-2023) & (K Units)
Figure 19. Global Flu (Influenza) Vaccine Sales Market Share by Application (2022)
Figure 20. Global Flu (Influenza) Vaccine Revenue Market Share by Application in 2022
Figure 21. Flu (Influenza) Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Flu (Influenza) Vaccine Sales Market Share by Company in 2022
Figure 23. Flu (Influenza) Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Flu (Influenza) Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Flu (Influenza) Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Flu (Influenza) Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Flu (Influenza) Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Flu (Influenza) Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Flu (Influenza) Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Flu (Influenza) Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Flu (Influenza) Vaccine
Figure 74. Industry Chain Structure of Flu (Influenza) Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Flu (Influenza) Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Application (2024-2029)
